Adiponectin
Meta Analysis
| Type | median CV estimate | lower CI limit | higher CI limit | Date Updated | Tools |
|---|---|---|---|---|---|
| Between-subject | 51.2 | 35.0 | 90.9 | 2019-10-20 21:11:45 UTC | |
References
No meta analysis Reference included in meta calculation Reference not included in meta calculation| Link | Estimate of CVi | Estimate of CVg | Gender | State of Well Being | Matrix |
|---|---|---|---|---|---|
| Biovariabiity of plasma adiponectin, Shand B, Elder P, Scott R Frampton C and Willis J, 2006, Clin Chem Lab Med, 44, 1264-8 | 18.8 | 51.2 | Mixed | Healthy (excl pregnant) | Plasma |
| Biovariabiity of plasma adiponectin, Shand B, Elder P, Scott R Frampton C and Willis J, 2006, Clin Chem Lab Med, 44, 1264-8 | 12.2 | 32.6 | Mixed | Non-healthy (excl pregnant) | Plasma |
| Biovariabiity of plasma adiponectin, Shand B, Elder P, Scott R Frampton C and Willis J, 2006, Clin Chem Lab Med, 44, 1264-8 | 17.9 | 54.3 | Mixed | Non-healthy (excl pregnant) | Plasma |
| Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk, Belobrajdic DP, Priebe IK, Forbes B, Flyvbjerg A, Chen JW, Cosgrove LJ, Frystyk J and Saunders IW, 2008, Growth Hormone and IGF Res, 18, 198-204 | 1.4 | 4.35 | Mixed | Healthy (excl pregnant) | Serum |